HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

HTI-286

a synthetic analog of the tripeptide hemiasterlin; structure in first source
Also Known As:
HTI 286; HTI286; N,beta,beta-trimethyl-L-phenylalanyl-L-N(1)-((1S,2E-3-carboxy-1-isopropylbut-2-enyl))-N(1),3-dimethyl-L-valinamide; SPA110; taltobulin
Networked: 12 relevant articles (0 outcomes, 3 trials/studies)

Bio-Agent Context: Research Results

Experts

1. Loganzo, Frank: 6 articles (05/2005 - 04/2003)
2. Andersen, Raymond J: 4 articles (08/2009 - 04/2003)
3. Greenberger, Lee M: 4 articles (05/2005 - 04/2003)
4. Zask, Arie: 4 articles (05/2005 - 04/2003)
5. Gleave, Martin E: 3 articles (08/2009 - 03/2008)
6. Hadaschik, Boris A: 3 articles (08/2009 - 03/2008)
7. Ayral-Kaloustian, Semiramis: 3 articles (05/2005 - 04/2003)
8. Hari, Malathi: 3 articles (05/2005 - 04/2003)
9. Musto, Sylvia: 3 articles (05/2005 - 04/2003)
10. Annable, Tami: 3 articles (11/2004 - 04/2003)

Related Diseases

1. Neoplasms (Cancer)
2. Urinary Bladder Neoplasms (Bladder Cancer)
3. Breast Neoplasms (Breast Cancer)
4. Carcinoma (Carcinomatosis)
5. Prostatic Neoplasms (Prostate Cancer)

Related Drugs and Biologics

1. hemiasterlin
2. Depsipeptides
3. Intercellular Signaling Peptides and Proteins (Growth Factors)
4. Fibroblast Growth Factor 1 (FGF-1)
5. Peptides (Polypeptides)
6. Epidermal Growth Factor (EGF)
7. Trabectedin
8. girolline
9. tasidotin
10. vitilevuamide

Related Therapies and Procedures

1. Therapeutics
2. Intravenous Administration
3. Drug Therapy (Chemotherapy)
4. Castration
5. Intravesical Administration